Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee.

Summary: Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disease that eventually weakens the heart, a condition known as cardiomyopathy. While doctors have long known that heart medications can help, there hasn't been a clear, unified rulebook on exactly when to start these drugs or how to adjust the dosages for the best results. To fix this, the ACTION muscular dystrophy committee—a group of experts—has created a new "roadmap" for cardiac care. By combining their expertise with established heart guidelines, they have produced standardized recommendations for starting and fine-tuning heart medications. This effort aims to eliminate confusion among healthcare providers and ensure that every patient with DMD gets the precise heart care they need to live longer, healthier lives.